Healthcare company also expects 25 significant brand-line extensions
NHS England backs Academic Health Science Networks to spread innovation
Follows state-supported schemes in Europe to combat resistance to antibiotics
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
CRO says new office will bolster its presence in the Middle East and North Africa
Inotuzumab ozogamicin fails to show survival benefit in phase III
OrphanReach alliance will see companies provide product lifecycle services
Chasing the cure for Parkinson's diseaseResearch for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
Bringing trial data out of the shadowsTransparency of clinical trial data has become a hotly disputed topic recently, how the industry at large will respond is still not clear, but as the noise grows louder, reputations
Promising new agents for multiple myelomaDrug development for this type of bone marrow cancer has been gaining momentum, with two new proteasome inhibitor approvals in the last year alone and a number of new treatments
Sanofi reconsiders closure plans in Toulouse after government pressureReport says research site can remain open with minimal job losses
Atlas Venture fund aims to create 15 new biotech companies
Merck KGaA forges clinical alliance with QuintilesCRO becomes sole outsourcing partner for pharma company
Firm will develop and distribute medicines in some of the world’s poorest countries
Research units to close as Astellas restructuresUS subsidiaries OSI Pharmaceuticals and Perseid Therapeutics among those affected
NIHR streamlines clinical trials service for pharmaAims to help speed up studies in the NHS in England
Another setback for Lilly as lymphoma drug failsLate-stage candidate enzastaurin shows disappointing phase III results
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
Dr Julian Howell joins Shield Therapeutics as group medical directorMineral medicines company also appoints Dr Lynn Drummond to the board
Endocyte appoints Parexel's Scot Harper to oversee clinical trialsHe also previously served at Novartis and Lilly
AP Pharma overhauls senior management teamBrings in former Pfizer R&D head as CEO in addition to new president and COO
Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team ...